Rasagiline Mesylate Tablets 1mg × 14 Tablets (Qingkaisha)

Rasagiline Mesylate Tablets 1mg × 14 Tablets (Qingkaisha)

$2.00

Rasagiline Mesylate Tablets (Brand: ??? / Qingkaisha) are monoamine oxidase-B (MAO-B) inhibitors used in neuropharmacological research. Each box contains 1?mg tablets ×?7 tablets ×?2 blisters (14 tablets). Manufactured by Jiangxi Kerui Pharmaceutical Co., Ltd., this compound is designed for experimental models related to Parkinson’s disease, neuroprotection, and dopamine metabolism.

EMI starting from $0.00/month - View Plans

Description

Rasagiline Mesylate is a selective MAO-B inhibitor commonly studied for its dopaminergic neuroprotection and anti-parkinsonian properties. It is structurally related to selegiline but has superior pharmacokinetics and fewer neurotoxic metabolites, making it ideal for preclinical CNS disease research.


Rasagiline Mesylate Tablets Product Specifications

ParameterDetails
Product NameRasagiline Mesylate Tablets
Generic NameRasagiline Mesylate
CAS Number176087-01-5
Molecular FormulaC12H13N·CH4O3S
Molecular Weight~267.34 g/mol
FormulationOral tablets
Strength1?mg per tablet
Pack Size14 tablets (7 tablets × 2 blisters)
Approval NumberH20233947 (NMPA, China)
Drug Code86905337001198
ManufacturerJiangxi Kerui Pharmaceutical Co., Ltd.
Product Barcode6975570690194
Storage ConditionsStore below 25?°C; protect from heat, moisture, and light
Intended UseFor laboratory research only

Rasagiline Mesylate Tablets Mechanism of Action

Rasagiline Mesylate selectively inhibits monoamine oxidase-B, preventing dopamine breakdown in the brain. It enhances synaptic dopamine levels, supports neuroplasticity, and is used in models of Parkinson’s disease, neurodegeneration, and oxidative stress modulation.


Research Applications

  • Parkinson’s Disease Models
    Enhances dopaminergic transmission; reduces motor deficits in rodent Parkinsonian models.

  • Neurodegenerative Disease Research
    Assists in the study of mitochondrial dysfunction, apoptosis, and neuroprotection.

  • Dopamine Metabolism Studies
    Suitable for evaluating dopamine turnover and MAO-B inhibitory kinetics.

  • Cognitive Function & Behavioral Pharmacology
    Explored for its influence on memory, learning, and motor coordination.


Handling & Storage

  • Handling: Use gloves and laboratory protective equipment.

  • Storage: Keep in a cool, dry place (<25°C). Do not expose to direct sunlight.

  • Shelf Life: Typically stable for 24–36 months in unopened packaging.


Research-Use Disclaimer

This product is intended for scientific research only. It is not approved for clinical, therapeutic, diagnostic, or human/veterinary consumption. Proper laboratory procedures and institutional safety guidelines must be followed at all times.

Additional information

Weight1 kg
Dimensions36 × 32 × 36 cm

Reviews

There are no reviews yet.

Be the first to review “Rasagiline Mesylate Tablets 1mg × 14 Tablets (Qingkaisha)”

Your email address will not be published. Required fields are marked *

Q1: What is the main use of Rasagiline Mesylate in lab studies?

A1: It is primarily used in Parkinson’s disease models, dopaminergic pathway analysis, and mitochondrial function studies.

Q2: Is this product intended for clinical use?

A2: No. This product is strictly for research use only and not approved for human or veterinary treatment.

Q3: Can I purchase this in bulk?

A3: Yes. Both wholesale and small-lot orders are accepted. Please contact us for distributor pricing.

Q4: Are documentation like COA and SDS available?

A4: Yes. Certificate of Analysis (COA) and Safety Data Sheet (SDS) can be provided upon request.

Q5: What makes Rasagiline different from Selegiline?

A5: Rasagiline is more potent, has a better side effect profile, and produces fewer amphetamine-like metabolites compared to selegiline.


EMI Options